Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Journal of Gastroenterology|October 12, 2012
The similarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltrationYuri Fukui, Kazushige Uchida, Kimi Sumimoto, et al.
Trials|August 11, 2019
The efficacy of polyglycolic acid felt reinforcement in preventing postoperative pancreatic fistula after pancreaticojejunostomy in patients with main pancreatic duct less than 3 mm in diameter and soft pancreas undergoing pancreatoduodenectomy (PLANET-PJ trial): study protocol for a multicentre randomized phase III trial in Japan and KoreaKazuto Shibuya, Jin-Young Jang, Sohei Satoi, et al.
Pancreas|June 25, 2026
Clinical Statistics and Outcomes of Pancreatic Neoplasms in Japan: A Retrospective Cohort Study using the Japan Pancreatic Cancer RegistryMasamichi Mizuma, Shinya Hirakawa, Hisateru Tachimori, et al.
Langenbeck'S Archives of Surgery|November 6, 2017
Reinforced staplers for distal pancreatectomyManabu Kawai, Seiko Hirono, Ken-Ichi Okada, et al.
Trials|November 10, 2018
MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinomaSeiko Hirono, Manabu Kawai, Ken-Ichi Okada, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|May 11, 2013
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic SurgerySohei Satoi, Hiroki Yamaue, Kentaro Kato, et al.
Annals of Surgery|August 7, 2025
Mesenteric Versus Conventional Approach During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma (MAPLE-PD trial): A Multicenter Randomized Controlled TrialSeiko Hirono, Yuji Kitahata, Hideki Motobayashi, et al.
Cancer Chemotherapy and Pharmacology|October 23, 2013
Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancerHiroki Yamaue, Sohei Satoi, Takamasa Kanbe, et al.
Pancreas|May 13, 2016
Clinicopathological Characteristics of Young Patients With Pancreatic Cancer: An Analysis of Data From Pancreatic Cancer Registry of Japan Pancreas SocietyHidetoshi Eguchi, Hiroki Yamaue, Michiaki Unno, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|December 2, 2021
Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study GroupSohei Satoi, Naminatsu Takahara, Tsutomu Fujii, et al.
Pageof 24